Published in AIDS Weekly, June 19th, 2006
According to recent research from Canada, "Several studies have shown that phosphorothioate oligodeoxynucleotides (PS-ONs) have a sequence-independent antiviral activity against human immunodeficiency virus type 1 (HIV-1).
"It has also been suggested that PS-ONs inhibit HIV-1 by acting as attachment inhibitors that bind to the V 3 loop of gpl20 and prevent the gp120-CD4 interaction."
"Here we show that PS-ONs (and their fully 2 '-O-methylated derivatives) are potent inhibitors of HIV-1-mediated membrane fusion and HIV-1 replication in a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.